Site-specific abnormalities in the visual system of a mouse model of CDKL5 deficiency disorder

被引:26
|
作者
Lupori, Leonardo [1 ,2 ]
Sagona, Giulia [2 ,3 ,4 ]
Fuchs, Claudia [5 ]
Mazziotti, Raffaele [2 ,3 ]
Stefanov, Antonia [2 ]
Putignano, Elena [2 ]
Napoli, Debora [1 ,2 ]
Strettoi, Enrica [2 ]
Ciani, Elisabetta [5 ]
Pizzorusso, Tommaso [1 ,2 ,3 ]
机构
[1] Scuola Normale Super Pisa, BIO SNS Lab, Via Moruzzi 1, I-56124 Pisa, Italy
[2] CNR, Inst Neurosci, Via Moruzzi 1, I-56124 Pisa, Italy
[3] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth NEURO, Area San Salvi Pad 26, I-50135 Florence, Italy
[4] IRCCS Stella Maris Fdn, Dept Dev Neurosci, I-56128 Pisa, Italy
[5] Univ Bologna, Dept Biomed & Neuromotor Sci, I-40126 Bologna, Italy
关键词
INTRINSIC SIGNAL; IMPAIRMENT; EXPRESSION; PHENOTYPES; NEURONS; MICE;
D O I
10.1093/hmg/ddz102
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CDKL5 deficiency disorder (CDD) is a neurodevelopmental disorder characterized by a severe global developmental delay and early-onset seizures. Notably, patients show distinctive visual abnormalities often clinically diagnosed as cortical visual impairment. However, the involvement of cerebral cortical dysfunctions in the origin of the symptoms is poorly understood. CDD mouse models also display visual deficits, and cortical visual responses can be used as a robust biomarker in CDKL5 mutant mice. A deeper understanding of the circuits underlying the described visual deficits is essential for directing preclinical research and translational approaches. Here, we addressed this question in two ways: first, we performed an in-depth morphological analysis of the visual pathway, from the retina to the primary visual cortex (V1), of CDKL5 null mice. We found that the lack of CDKL5 produced no alteration in the organization of retinal circuits. Conversely, CDKL5 mutants showed reduced density and altered morphology of spines and decreased excitatory synapse marker PSD95 in the dorsal lateral geniculate nucleus and in V1. An increase in the inhibitory marker VGAT was selectively present in V1. Second, using a conditional CDKL5 knockout model, we showed that selective cortical deletion of CDKL5 from excitatory cells is sufficient to produce abnormalities of visual cortical responses, demonstrating that the normal function of cortical circuits is dependent on CDKL5. Intriguingly, these deficits were associated with morphological alterations of V1 excitatory and inhibitory synaptic contacts. In summary, this work proposes cortical circuit structure and function as a critically important target for studying CDD.
引用
收藏
页码:2851 / 2861
页数:11
相关论文
共 50 条
  • [41] Measuring the Burden of Epilepsy Hospitalizations in CDKL5 Deficiency Disorder
    Junaid, Mohammed
    Wong, Kingsley
    Korolainen, Minna A.
    Amin, Sam
    Downs, Jenny
    Leonard, Helen
    PEDIATRIC NEUROLOGY, 2025, 163 : 68 - 75
  • [42] Gut microbiota profile in CDKL5 deficiency disorder patients
    Borghi, Elisa
    Xynomilakis, Ornella
    Ottaviano, Emerenziana
    Ceccarani, Camilla
    Vigano, Ilaria
    Tognini, Paola
    Vignoli, Aglaia
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [43] Effect of ganaxolone on behaviors in children with the CDKL5 Deficiency Disorder
    Downs, J.
    Aimetti, A.
    Busse, G.
    Jacoby, P.
    ANNALS OF NEUROLOGY, 2022, 92 : S89 - S90
  • [44] Electrophysiological biomarkers of brain function in CDKL5 deficiency disorder
    Saby, Joni N.
    Mulcahey, Patrick J.
    Zavez, Alexis E.
    Peters, Sarika U.
    Standridge, Shannon M.
    Swanson, Lindsay C.
    Lieberman, David N.
    Olson, Heather E.
    Key, Alexandra P.
    Percy, Alan K.
    Neul, Jeffrey L.
    Nelson, Charles A.
    Roberts, Timothy P. L.
    Benke, Timothy A.
    Marsh, Eric D.
    BRAIN COMMUNICATIONS, 2022, 4 (04)
  • [45] Early-onset brain alterations during postnatal development in a mouse model of CDKL5 deficiency disorder
    Tassinari, Marianna
    Uguagliati, Beatrice
    Trazzi, Stefania
    Cerchier, Camilla Bruna
    Cavina, Ottavia Vera
    Mottolese, Nicola
    Loi, Manuela
    Candini, Giulia
    Medici, Giorgio
    Ciani, Elisabetta
    NEUROBIOLOGY OF DISEASE, 2023, 182
  • [46] Ganaxolone for management of seizures associated with CDKL5 deficiency disorder
    Yasmen, Nelufar
    Sluter, Madison N.
    Yu, Ying
    Jiang, Jianxiong
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2023, 44 (02) : 128 - 129
  • [47] Influences on the trajectory and subsequent outcomes in CDKL5 deficiency disorder
    Leonard, Helen
    Junaid, Mohammed
    Wong, Kingsley
    Aimetti, Alex A.
    Knight, Elia Pestana
    Downs, Jenny
    EPILEPSIA, 2022, 63 (02) : 352 - 363
  • [48] Functional and Structural Impairments in the Perirhinal Cortex of a Mouse Model of CDKL5 Deficiency Disorder Are Rescued by a TrkB Agonist
    Ren, Elisa
    Roncace, Vincenzo
    Trazzi, Stefania
    Fuchs, Claudia
    Medici, Giorgio
    Gennaccaro, Laura
    Loi, Manuela
    Galvani, Giuseppe
    Ye, Keqiang
    Rimondini, Roberto
    Aicardi, Giorgio
    Ciani, Elisabetta
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2019, 13
  • [49] CDKL5 Deficiency Disorder-A Complex Epileptic Encephalopathy
    Jakimiec, Martyna
    Paprocka, Justyna
    Smigiel, Robert
    BRAIN SCIENCES, 2020, 10 (02)
  • [50] CDKL5 deficiency disorder: Relationship between genotype, epilepsy, cortical visual impairment, and development
    Demarest, Scott T.
    Olson, Heather E.
    Moss, Angela
    Pestana-Knight, Elia
    Zhang, Xiaoming
    Parikh, Sumit
    Swanson, Lindsay C.
    Riley, Katherine D.
    Bazin, Grace A.
    Angione, Katie
    Niestroj, Lisa-Marie
    Lai, Dennis
    Juarez-Colunga, Elizabeth
    Benke, Tim A.
    EPILEPSIA, 2019, 60 (08) : 1733 - 1742